Matches 1 - 50 out of 80 1 2 >
Match Document Document Title
7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells  
The present invention provides compositions and methods of using embryonic-like stem cells that originate from a post-partum placenta with conventional cord blood compositions or other stem or...
7311904 Tissue matrices comprising placental stem cells, and methods of making the same  
A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The method sets forth collecting embryonic stem cells from a placenta which has been treated to remove...
6660305 Composition for stimulating the synthesis of the melanic pigment and process for obtaining it  
This invention relates to the field of human medicine, more specifically to dermatology, and in particular to a composition developed for the stimulation of the synthesis of the melanic pigment of...
6638520 Structures and methods for promoting vascularization  
One aspect of the present invention provides implantable medical devices that comprise: (a) a device body; and (b) a surface layer attached to at least a portion of the device body, the surface...
6605275 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood  
The present invention relates to hematopoietic stem and progenitor cells of neonatal or fetal blood that are cryopreserved, and the therapeutic uses of such stem and progenitor cells upon thawing....
6277828 Pharmaceutical formulations of nerve growth factor  
Stable, aqueous pharmaceutical formulations of human nerve growth factor (NGF) in aqueous isotonic solutions, buffered to maintain the pH from about 4.5 to about 6.0, and optionally containing a...
6183749 Dietary supplement containing herbal extracts which promotes healthy hair growth on the scalp  
A composition of a dietary supplement comprising MAMMALIA PLACENTA prepared from the placenta of a mammal, FRUCTUS LIGUSTRI LUCIDI, SALVIAE MILTIORRHIZAE, PAEONIAE RUBRA, CINNAMOMI CASSIAE, MOUTAN...
5707657 Food supplement containing animal fetal mesenchymal matter and animal fetal organ extracts  
A food supplement comprises isolated animal mesenchymal matter of fetal origin and extracts of animal organs of fetal origin, the mesenchymal matter consisting of a network of loose connective...
5690966 Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo  
A process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like peptides useful for the treatment of vitiligo is disclosed.
5558875 Method of preparing collagenous tissue  
A process of preparation of a collagenous prosthesis for removing cell membrane proteins from a biological collagenous tissue and preserving elasticity of the collagenous prosthesis comprises the...
5512304 Method of preparing a thromboplastin extract  
A thromboplastin extract including an aqueous thromboplastin extract of a powdered thromboplastin source including a metal ion chelator. A thromboplastin reagent for use in blood coagulation tests,...
5391380 Thromboplastin extract, reagent, and preparation thereof  
A thromboplastin extract including an aqueous thromboplastin extract of a powdered thromboplastin source including a metal ion chelator. A thromboplastin reagent for use in blood coagulation tests,...
5324822 Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid  
A method of isolation of a material with similar immunological properties to CA-195 from human amniotic fluid has been disclosed. This material can be substituted for CA-195 in many processes, for...
5296467 Composition comprising an anticoagulant  
Pharmaceutical compositions which consist essentially of a vascular anticoagulant annexine, Ca 2 +, Zn 2 +, and a pharmaceutically acceptable carrier are disclosed. Also disclosed are processes for...
5210185 Human nerve growth factor  
The present invention is directed to a method for the isolation of Human Nerve Growth Factor (HNGF) from human placenta. More particularly, the invention is directed to the method of isolation of...
5180743 Anti-inflammatory and analgesic compounds, related compositions and methods for preparation and use thereof  
This application relates to an anti-inflammatory, immunosuppressive and analgesic composition, a method for its preparation, a pharmaceutical composition including it and a method of treating...
5175005 Method of controlling lung tumor cell metastasis  
A method of controlling tumor cell metastasis comprising administering to a human a therapeutically effective amount of a ribonuclease inhibitor.
5169835 Pregancy specific proteins applications  
At least seven genes have been identified which encode proteins generally identified as pregnancy specific protein (SP1), also known as pregnancy specific beta glycoprotein (PSBG). These genes have...
5149535 Process for the modification of whey  
Method for the manufacture of modified whey with the assistance of lactic acid bacteria for use in manufacturing washing-active substances, as well as, cosmetic and pharmaceutical products,...
5055485 Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides  
A process of inactivating infectious viruses in a cell-containing or a protein-containing composition containing such viruses, comprising contacting such composition with an effective amount of at...
5002071 Injectable soft tissue augmentation materials from the placenta and their method of manufacture  
Disclosed is a soft tissue augmentation material from human placenta homogenized to pass through a surgical needle, preferably a 30 gauge surgical needle, and cross-linking collagen molecules of...
4996057 Composition for locally treating the epidermis, especially the scalp  
The object of the invention is a composition for the local treatment of the epidermis comprising at least two active constituents, characterized in that one of these constituents is a product...
4985255 External preparations of melanogenesis-inhibitory agent  
External preparations of 1 melanogenesisinhibitory agent contain, as active ingredients, a placental extract of pregnant cows and kojic acid or a derivative thereof. The placental extract of...
4906461 Hair treatment composition  
A hair treatment which replaces properties of hair which has been treated with a chemical treatment such as perming, coloring or straightening is disclosed. The present invention may be formulated...
4876241 Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants  
A method of inactivating pathogens in proteinaceous biological and pharmaceutical products which comprises: mixing the product in an aqueous solution with one or more primary stabilizers selected...
4873222 Placenta-derived anticoagulating substance  
A human placenta-derived antiocoagulating substance is prepared by homogenizing a human plancenta, subjecting the resulting homogenate to centrifugal separation, extracting the thus-obtained...
4748156 Thrombin-binding substance and process for preparing the same  
A novel thrombin-binding substance having the characteristics of (a) molecular weight: 47,000±6,000 in reduced condition and 38,000±6,000 in unreduced condition, (b) isoelectric point: pH...
4696813 Melanin inhibiting cosmetic composition  
Placenta extracts and kojic acid or kojic acid derivatives are formulated into cosmetic bases to make cosmetic compositions. The cosmetic compositions exhibit an enhanced whitening effect for the...
4673733 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents  
A method for treating a biological or pharmaceutical product to inactivate viruses and pyrogens therein comprising the steps of adsorbing said product onto a solid phase; treating the adsorbed...
4638050 Thrombin-binding substance and process for its production  
A thrombin-binding substance derived from human tissue and having the characteristics of (a) molecular weight: 88,000±20,000 in reduced condition and 71,000±20,000 in unreduced condition; (b)...
4599226 Wound dressing comprising silver sulfadiazine incorporated in animal tissue and method of preparation  
Animal tissue and the like having silver sulfadiazine incorporated therein is useful as a covering for burns and/or wounds. The silver sulfadiazine is incorporated in the tissue by soaking the...
4597899 Process for obtaining a factor XIII preparation, and its use  
A process for obtaining a factor XIII preparation is described, in which the factor XIII is precipitated from a placental extract using an alcohol, and is adsorbed onto an anion exchanger, and the...
4576696 Process for the preparation of a biologically active extract  
A mammal organ, for example the thymus, or a cell culture is comminuted to form a slurry, accompanied by cell disintegration, high molecular weight substances are precipitated by heating and...
4524027 Membrane-associated proteins (MP.sub.2), a process for obtaining them, and their use  
Membrane-associated proteins, called MP 2 , and a process for obtaining them are described. The proteins have the following parameters: (a) an electrophoretic mobility in the range between that...
4507277 Composition and method for stimulating the synthesis of the melanotic pigment of the skin  
A composition useful in the treatment of vitiligo, a method for preparing said composition and a method of treating vitiligo with said composition wherein said composition comprises a placental...
4507229 Tissue protein PP.sub.4, a process for isolating it and its use  
The protein PP 4 which has (a) an electrophoretic mobility in the range between that of α 1 and α 2 globulins; (b) an isoelectric point of 4.85±0.15; (c) a sedimentation coefficient...
4505893 Purified plasminogen activator, process for its production and thrombolytic composition containing it  
A plasminogen activator obtained from a tissue cultured liquor of human normal tissue derived cells, e.g., human embryonic derived cells, human placenta derived cells etc., and having the following...
4468345 Protein (PP.sub.17), a process for concentrating and isolating it and its use  
The protein PP 17 , which has (a) an electrophoretic mobility in the range between β 1 - and α 2 -globulins, (b) an isoelectric point of 5.25±0.20, (c) a sedimentation coefficient S 20 o , w...
4423036 Acid soluble platelet aggregating material isolated from human umbilical cord  
Acid soluble, pepsin sensitive platelet aggregating material isolated from human umbilical cord tissue by extraction with dilute aqueous acid, method of isolation and use to control bleeding.
4402872 Protein and process for isolating it  
What are disclosed are an isolated tissue protein, denominated PP16, which can be used to prepare anti-sera useful as diagnostic agents, said protein being found in extracts of some human organs...
4368148 Protein PP.sub.9, process for its enrichment and its isolation and its use  
What are disclosed are a protein, PP 9 , useful for the diagnosis and monitoring of diseases involving tissue degradation, and a method for its isolation, said protein having: (a) a content of...
4335040 Therapeutic product and method  
Described herein are compositions obtained in accordance with the procedure which comprises placing in a pressure vessel a quantity of material comprising animal tissue selected from the group...
4325866 Protein, PP.sub.11, a process for its preparation and its use  
What are disclosed are a new protein, PP 11 , obtainable from placental tissue, methods for isolating the protein in concentrated form, methods for making an antiserum to said protein, and methods...
4315919 Depyrogenation process  
Biological and pharmaceutical products which are contaminated with pyrogens are depyrogenated by prolonged contact with a solution or suspension of from about 0.25% to about 10% by weight of a...
4285933 Process for concentrating blood coagulation Factor XIII derived from human placentae  
The invention relates to a process for concentrating blood coagulation Factor XIII (Fibrin stabilizing factor) which comprises removing a fraction precipitated at a pH of 6 to 9 in a concentration...
4269825 New glycoprotein and process for isolating it  
A new glycoprotein is characterized by a protein consisting essentially of 75±6% of α-amino-acids, a carbohydrate portion of 24.6±5.2%, which contains 8.9±2% of hexoses, 7.1±1.5 of...
4254021 Tissue specific protein and process for preparing same  
The invention relates to a tissue specific protein, i.e. a substance which is a constituent of parenchymatous tissues, and to a process for preparing the same. The tissue protein is characterized...
4219467 Method for the preparation of chorionic human somatomammotropin  
A method is disclosed for extracting human chorionic somatomammotropin (HCS) which comprises the steps of separating from placental extract a proteinic fraction which contains such hormone,...
4193992 Process for the preparation of defibrinated and lyophilized placental cells  
Defibrinated and lyophilized placental cells are prepared by taking the foetomaternal placenta of a ewe killed at the end of the fourth month of gestation, breaking the placenta into fragments,...
4169139 Glyco/proteinaceous materials derivable from beef liver and other tissues useful for the treatment of toxic and allergic conditions  
Mucoprotides (i.e., complex compounds of protein with carbohydrates and carbohydrate derivatives) derived from animal tissues, for example, mammalian liver by a succession of extractive steps...
Matches 1 - 50 out of 80 1 2 >